Suppr超能文献

美国长期治疗后同伴康复支持服务的成本效益

The cost-effectiveness of long-term post-treatment peer recovery support services in the United States.

作者信息

Castedo de Martell Sierra, Moore Margaret Brannon, Wang Hannah, Holleran Steiker Lori, Wilkerson J Michael, Ranjit Nalini, McCurdy Sheryl A, Brown H Shelton

机构信息

Chestnut Health Systems, Lighthouse Institute, Bloomington, IL, USA.

School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.

出版信息

Am J Drug Alcohol Abuse. 2025 Mar 4;51(2):180-190. doi: 10.1080/00952990.2024.2406251. Epub 2025 Mar 6.

Abstract

Peer recovery support services (PRSS) have been widely adopted across a variety of settings, but little is known about their economic impact. To conduct a cost-effectiveness analysis of long-term, PRSS delivered after specialty substance use disorder (SUD) treatment (post-treatment), and to describe the development of a free, web-based cost-effectiveness calculator based on this analysis. Using publicly available data from a variety of sources, post-treatment PRSS were compared to specialty SUD treatment from the societal (broad perspective including costs like participant time) and health systems perspectives (only costs borne by health system), and in terms of quality-adjusted life years (QALYs) added and people in recovery. Whenever possible, 2019 data were used to avoid the impacts of COVID-19. Standard willingness-to-pay thresholds and additional treatment episode cost ($17,203.74) were used. One-way and probabilistic sensitivity analyses were conducted. Two recovery community organizations (RCOs) were involved in model refinement and calculator development in 2022. Post-treatment PRSS were cost-effective to all thresholds and perspectives: $5,898.60 per QALY and $10,562.08 per person in recovery from the health system perspective, and $3,421.58 per QALY and $6,126.72 per person in recovery from the societal perspective, and post-treatment PRSS remained cost-effective across a variety of conditions in the sensitivity analyses. A cost-effectiveness calculator was developed from the analysis and is available at https://go.uth.edu/cea. In light of finding PRSS cost-effective, the expansion of PRSS across the US should continue, and may be aided by using the cost-effectiveness calculator to estimate tailored results for a specific program.

摘要

同伴康复支持服务(PRSS)已在各种环境中广泛采用,但对其经济影响却知之甚少。开展对专业物质使用障碍(SUD)治疗后(治疗后)提供的长期PRSS的成本效益分析,并描述基于该分析开发的免费网络成本效益计算器。利用来自各种来源的公开可用数据,从社会(包括参与者时间等成本的广泛视角)和卫生系统视角(仅卫生系统承担的成本),并就增加的质量调整生命年(QALY)和康复者数量,将治疗后的PRSS与专业SUD治疗进行比较。尽可能使用2019年的数据以避免COVID-19的影响。使用了标准支付意愿阈值和额外治疗疗程成本(17,203.74美元)。进行了单向和概率敏感性分析。两个康复社区组织(RCO)参与了2022年的模型优化和计算器开发。治疗后的PRSS在所有阈值和视角下均具有成本效益:从卫生系统视角看,每QALY为5,898.60美元,每康复者为10,562.08美元;从社会视角看,每QALY为3,421.58美元,每康复者为6,126.72美元,且在敏感性分析中,治疗后的PRSS在各种情况下仍具有成本效益。根据该分析开发了一个成本效益计算器,可在https://go.uth.edu/cea获取。鉴于发现PRSS具有成本效益,在美国扩大PRSS的工作应继续进行,使用成本效益计算器估计特定项目的定制结果可能会有所帮助。

相似文献

本文引用的文献

4
Cost-effectiveness of Treatments for Opioid Use Disorder.阿片类药物使用障碍治疗的成本效益。
JAMA Psychiatry. 2021 Jul 1;78(7):767-777. doi: 10.1001/jamapsychiatry.2021.0247.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验